Patents Assigned to Whitenead Institute for Biomedical Research
  • Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
    Patent number: 5951976
    Abstract: Disclosed are methods and compositions wherein opsonin-enhanced cells, that is, cells which have been 1) modified so as to express an opsonin from a recombinant nucleic acid, 2) modified so as to express higher levels of an endogenous opsonin, or 3) mixed with an exogenous opsonin, when administered to a subject, modulate the immune response in the recipient to a selected antigen or antigens contained in or attached to the cells.
    Type: Grant
    Filed: March 27, 1997
    Date of Patent: September 14, 1999
    Assignee: Whitenead Institute for Biomedical Research
    Inventor: Andrew H. Segal